Prentiss Smith & Co’s Hologic HOLX Stock Holding History

Prentiss Smith & Co’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,510	Closed	-$2.38M	–	68
2026 Q1	$2.38M	Sell	31,510 -650	-2%	-$48.9K	1.38%	25
2025 Q4	$2.4M	Sell	32,160 -142	-0.4%	-$10.4K	1.43%	25
2025 Q3	$2.18M	Sell	32,302 -548	-2%	-$36.4K	1.23%	27
2025 Q2	$2.14M	Sell	32,850 -15,544	-32%	-$932K	1.27%	27
2025 Q1	$2.99M	Sell	48,394 -264	-0.5%	-$17.5K	1.94%	22
2024 Q4	$3.51M	Sell	48,658 -38	-0.1%	-$2.97K	2.3%	19
2024 Q3	$3.97M	Buy	48,696 +130	+0.3%	+$10.4K	2.54%	15
2024 Q2	$3.61M	Sell	48,566 -414	-0.8%	-$31K	2.51%	18
2024 Q1	$3.82M	Buy	+48,980	New	+$3.64M	2.68%	17

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Prentiss Smith & Co's HOLX Position: Q2 2026 in Review

Prentiss Smith & Co sold out of Hologic (HOLX) in Q2 2026, closing a stake of 31,510 shares — an estimated $2.38M sold.

Prentiss Smith & Co first reported a position in HOLX in Q1 2024 and held it in 9 quarters. The position peaked at $3.97M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Prentiss Smith & Co reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Prentiss Smith & Co sold 31,510 Hologic shares in Q2 2026, an estimated $2.38M.
Prentiss Smith & Co first reported a position in Hologic in Q1 2024 and held it in 9 quarters.
Prentiss Smith & Co's Hologic position peaked at $3.97M in Q3 2024.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Prentiss Smith & Co's 13F filing for Q2 2026, filed 30 Jul 2026.